Sign in
4/A

Changes in Ownership

Alzamend Neuro, Inc. Filed Acc 0001214659-22-004992

Director sold 25,000 shares at $1.21 ($30,325)

From the SEC's structured data for this filing

Trades in this filing

McGrath Lynne Fahey · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-03-28 Sale : show line 1 in the form −25,000 $1.21 $30,325 75,000 D
Open-market sales · 25,000 sh · avg $1.21 · $30,325
Loading xslF345X03/marketforms-55978.xml…